(最終更新日:2019-09-13 11:04:00)
  オガワ ヒロシ   HIROSHI OGAWA
  小川 洋司
   所属   医学部 医学科(東京女子医科大学病院)  循環器内科
   職種   准教授
■ 著書
1. 部分執筆  HIJ-CREATE「高血圧ナビゲーター 第3版」 2011/06
■ 学術雑誌
1. 原著  Optimal Blood Pressure in Patients With Coronary Artery Disease and Chronic Kidney Disease: HIJ-CREATE Substudy. 2019/06
2. 原著  Pilot Cohort Study Assessing the Efficacy of Endovascular Revascularization in the Restoration of Peripheral Sensory Disturbance in Patients With Critical Limb Ischemia. 2017/07 Link
3. 原著  Lesion characteristics of coronary arteries associated with a mismatch between angiographic severity of stenosis and fractional flow reserve. 2017/04 Link
4. 原著  Low-density lipoprotein cholesterol targeting with pitavastatin + ezetimibe for patients with acute coronary syndrome and dyslipidaemia: the HIJ-PROPER study, a prospective, open-label, randomized trial. 2017/04
5. 原著  Rationale, design features, and baseline characteristics: The Heart Institute of Japan-PRoper level of lipid lOwering with Pitavastatin and Ezetimibe in acute coRonary syndrome (HIJ-PROPER). 2017/03 Link
6. 原著  Intimal disruption affects drug-eluting cobalt-chromium stent expansion: A randomized trial comparing scoring and conventional balloon predilation. 2016/10 Link
7. 原著  Randomized pilot trial comparing tolvaptan with furosemide on renal and neurohumoral effects in acute heart failure. 2016/09 Link
8. 原著  Efficacy of 24-Hour Blood Pressure Monitoring in Evaluating Response to Percutaneous Transluminal Renal Angioplasty. 2016/08
9. 原著  Impact of left ventricular ejection function on blood pressure-lowering therapy in hypertensive patients with coronary artery disease. 2016/05 Link
10. 原著  Effect of Hemodialysis on 7-Year Clinical Outcomes After Sirolimus-Eluting Stent Implantation. 2015/08
全件表示(40件)
■ 学会発表
1. Differences in the usefulness of aggressive lipid-­lowering therapy among single-vessel and multi-vessel coronary artery disease patients: HIJ-­PROPER sub-­study (ポスター,一般) 2019/08/31
2. The clinical impact of polyunsaturated fatty acid on clinical outcomes in acute coronary syndrome with dyslipidemia: HIJ-PROPER sub-analysis (ポスター,一般) 2019/08/31
3. Differences in the Usefulness of Aggressive Lipidlowering Therapy among Single-vessel and Multivessel Coronary Artery Disease Patients: HIJPROPER Sub-study (口頭発表,一般) 2019/03/31
4. Haemoglobin A1c (HbA1c) in Diabetic Patients with Myocardial Infarction: Is HbA1c an Independent Risk Factor and Predictor of Adverse Outcome? (口頭発表,一般) 2019/03/31
5. Target Systolic Blood Pressure For Preventing Cardiovascular Outcomes In Patients With Dyslipidemia Receiving Aggressive Lipid-.lowering Therapy: Findings of the HIJ-PROPER Trial (ポスター,一般) 2018/11/12
6. Effect of Combination Theraphy With Ezetimibe And Pitavastatin On Cardiovascular Outcomes in Patients With And Without Hypertension: Findings Of The HIJ-Proper Trial (ポスター,一般) 2018/11/10
7. Impact of Baseline Low-Density Lipoprotein cholesterole Level and Aggressive Lipid-Lowering Therapy by Ezetimibe on Prognosis of Statin Naive Acute Coronary Syndrome Patients: A Sub-Analysis of the HIJ-PROPER Trial (ポスター,一般) 2018/11/10
8. Simple risk score for predicting secondary cardiovascular events in ACS patients undergoing contemporary aggressive lipid-lowering management for dyslipidaemia: a sub-analysis of the HIJ-PROPER study (ポスター,一般) 2018/08/28 Link
9. Comparison of risk factors for cardiovascular outcomes between patients with and without diabetes: results from the HIJ-PROPER Study (ポスター,一般) 2018/08/26 Link
10. Antithrombotic Therapy in Patients with Atrial Fibrillation and Hemodialysis Undergoing Percutaneous Coronary Intervention -Results from a Multicenter Registry (口頭発表,一般) 2018/03/25
全件表示(77件)
■ 社会における活動
1. 2016/03 (特別講演座長)腎内血流と高血圧・循環器疾患/第2回 NCD Joint Meeting
2. 2018/09 (座長)一般演題(e-ポスター)24 虚血性心疾患 2 /第66回日本心臓病学会学術集会
■ 学歴
1. 島根医科大学 医学部 卒業 博士(医学)